Skip to main content

Chemed Corp

corporate_fare Company Profile

Chemed Corp

CHE·NYSE·Industrial Applications And Services·CIK 0000019584

Chemed purchases, operates, and divests subsidiaries across diverse business activities to maximize shareholder value. The company's day-to-day operating businesses are managed on a decentralized basis, with few integrated business functions like sales, marketing, or purchasing between the operating units and Chemed. Chemed's corporate office management handles long-term strategic planning, significant capital allocation decisions, investment activities, financial reporting, tax, legal, and the selection of key executives for each operating business. Since its inception, Chemed has completed twelve significant acquisitions or divestitures of diverse business units. During 2025, Chemed operated in two segments: VITAS and Roto-Rooter. The VITAS segment provides hospice and palliative care services through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. The Roto-Rooter segment offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers.

Chemed Corp (NYSE:CHE) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 14 items for CHE at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-29, rated 7/10. Across its 14 most recent items scored 7 or higher, the top rating is 8/10, with 9 rated 8 or above. Recent SEC coverage for CHE spans 10-Q, 8-K, DEF 14A, 10-K.

Recent high-impact activity:

  • Chemed 10-Q Details Q3 Beat, $60.6M RotoCo Deal and $236M Debt Load
  • Chemed Posts 3Q EPS of $5.45
  • Chemed Beats Q2 Estimates, Raises Full-Year Guidance on Hospice Strength
  • Chemed Beats Q2 Estimates, Raises Full-Year Guidance on VITAS Strength
  • Chemed Q2 Revenue Beats, Raises 2026 EPS Guidance on VITAS Strength

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
2.53B
Net Income
265.24M
Diluted EPS
18.34
Op. Cash Flow
388.27M
Free Cash Flow
325.48M
Gross Profit
823.18M
Operating Income
338.25M
Cash & Equivalents
74.52M
Debt / Equity
0.00×
Net Margin
10.5%
Shares Outstanding
14.4M sh
Source: 10-K · filed 2026-02-27 · accession 0001562762-26-000020

Short Interest & Short Volume

5.05 days to cover

FINRA reported short interest of 795,988 shares in CHE as of the October 30, 2026 settlement, a 16.0% increase from the prior period — about 5.0 days to cover at its recent average daily volume. On November 20, 2026, 77.3% of CHE volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)795,988 shares as of October 30, 2026
Change vs prior period▲ 16.0%
Days to cover5.05 at avg daily volume of 157,550
Daily short volume (FINRA facilities)77.3% of 58,123 shares on November 20, 2026
5-day average short volume70.7%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with C →
$548.7 +0.02% today
52-week range · as of 2026-10-29 $365.2 – $562.24
Market cap
$7.14B
Volume
160.2K (1.0× avg)
3-mo avg 155.2K
Live data · 2026-11-21 11:26 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CHE - Latest Insights

CHE
Oct 29, 2026, 9:00 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $534.88
Real-time Price: $548.70 info
Change: +$13.82 (+3%) info
Market Cap: $7.14B info
CHE
Oct 27, 2026, 4:15 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $509.09
Real-time Price: $548.70 info
Change: +$39.61 (+8%) info
Market Cap: $7.14B info
CHE
Jul 31, 2026, 9:04 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $540.00
Real-time Price: $548.70 info
Change: +$8.70 (+2%) info
Market Cap: $7.14B info
CHE
Jul 28, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $530.37
Real-time Price: $548.70 info
Change: +$18.33 (+3%) info
Market Cap: $7.14B info
CHE
Jul 28, 2026, 4:28 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $530.37
Real-time Price: $548.70 info
Change: +$18.33 (+3%) info
Market Cap: $7.14B info
CHE
Jul 21, 2026, 8:15 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $515.11
Real-time Price: $548.70 info
Change: +$33.59 (+7%) info
Market Cap: $7.14B info
CHE
May 19, 2026, 10:43 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $443.20
Real-time Price: $548.70 info
Change: +$105.50 (+24%) info
Market Cap: $7.14B info
CHE
Apr 28, 2026, 9:00 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $422.72
Real-time Price: $548.70 info
Change: +$125.98 (+30%) info
Market Cap: $7.14B info
CHE
Apr 23, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $422.00
Real-time Price: $548.70 info
Change: +$126.70 (+30%) info
Market Cap: $7.14B info
CHE
Apr 23, 2026, 4:26 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $397.14
Real-time Price: $548.70 info
Change: +$151.56 (+38%) info
Market Cap: $7.14B info
CHE
Apr 13, 2026, 9:03 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $385.84
Real-time Price: $548.70 info
Change: +$162.86 (+42%) info
Market Cap: $7.14B info
CHE
Apr 06, 2026, 9:00 AM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $379.93
Real-time Price: $548.70 info
Change: +$168.77 (+44%) info
Market Cap: $7.14B info
CHE
Feb 27, 2026, 9:36 AM EST
Filing Type: 10-K
Importance Score:
7
Price at Filing: $396.05
Real-time Price: $548.70 info
Change: +$152.65 (+39%) info
Market Cap: $7.14B info
CHE
Feb 25, 2026, 4:30 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $466.60
Real-time Price: $548.70 info
Change: +$82.10 (+18%) info
Market Cap: $7.14B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets